PE Tech Report

Latest News

Apposite Capital, a private equity firm specialising in healthcare, has made an initial investment of EUR7 million in NIMGenetics, a genetic diagnostic laboratory based in Spain. The company is operating in a fast-growing market and generated 34 per cent in revenue growth last year.   Apposite’s investment will enable NIMGenetics to further develop its service offering as well as support its international expansion, especially in Latin America.   NIMGenetics uses the latest genomic technologies to offer products and services in a number of medical areas including pre-natal testing, gynaecology, neurology, paediatrics, cardiology and oncology. The company was created in 2008 and
Hugues Gillibert, Fitz Partners
Independent fund research company Fitz Partners gives an insight into the calculations of funds’ performance fees and their choice of benchmarks in the latest edition of its Performance Fee Benchmarking Report and Database. Hugues Gillibert (pictured), chief executive officer of Fitz Partners, says: “In light of growing discussions on how asset managers should be charging for ‘value’ and the alignment of investors and fund managers’ interests through the possible development of performance related fees, a deep understanding of performance fee structures is critical. Our latest Performance Fee Benchmarking report and database, offers the means to easily compare and analyse different performance
Morrison Street Capital’s Morrison Street Debt Opportunities Fund (MSDO) has reached its target with total equity commitments of USD200 million. MSDO provides small-balance mezzanine capital, with investment balances generally ranging from USD2 million to USD10 million, to real estate market participants across a diversified set of property types in the top 100 MSAs nationwide.   MSDO’s investments are structured as either mezzanine debt, B-notes or preferred equity, tailored to meet the specific needs of each situation.   Morrison Street Capital formed MSDO to capitalise on the current opportunity in the debt capital markets, as well as to leverage its experience
SSA & Company has appointed Philippe Rose as managing director. Rose, who brings over 25 years of experience in chemicals and management consulting, will grow and lead the firm's European private equity and industrials practice having formerly run Celerant's Europe, Middle East and Asia (EMEA) private equity practice.   In that role, he covered the full M&A cycle, from due diligence to post-merger integration, across multiple sectors as well as working on the sell side in chemicals and pharmaceuticals.   "Increasingly, our clients ask for support of their global businesses," says Paul de Janosi, senior managing director at SSA. "Philippe
PenderFund Capital Management, the manager of the Pender suite of investment and alternative funds, has appointed Maria Pacella to its investment management team. Pacella joins Pender as senior vice president of private equity.   She has 16 years of experience of investing in emerging growth companies, mostly in the areas of information technology and med-tech. This experience includes operational roles, M&A facilitation and board memberships. She has built an extensive technology network across North America, notably in Silicon Valley. She is an active member and a past President of CFA Society, Vancouver.   Pacella joins Pender to launch a private
Balance Point Capital, in conjunction with one of its affiliated funds, Balance Point Capital Partners II, has provided debt and an equity co-investment to Apex Learning in support of Education Growth Partners' (EGP) acquisition of the company. Founded in 1997 and headquartered in Seattle, WA, Apex provides a SaaS-based digital curriculum for secondary education.   Apex offers a rigorous, standard-based curriculum to schools and districts nationwide to meet the needs of all students from those who are struggling to those who are capable of accelerating through two product offerings, Comprehensive Courses and Adaptive Tutorials.    Comprehensive Courses provide a proven
Surgery Partners is to merge with National Surgical Healthcare (NSH) after acquiring the company from Irving Place Capital for approximately USD760 million. Funding for Surgery Partners’ acquisition of NSH will be provided in part by Bain Capital Private Equity, who as part of the transaction, is injecting capital in exchange for a preferred security in the company.   In conjunction with this transaction, Bain Capital Private Equity will acquire HIG Capital’s existing equity stake in Surgery Partners.   The transaction builds upon each company’s physician-centric services model. It creates a diversified inpatient and outpatient surgical provider with a portfolio of
Handshake 2
K&L Gates has appointed Giovanni Meschia as a partner in the investment management, hedge funds and alternative investments practice in the firm’s Milan office. He joins K&L Gates from Jones Day.   Meschia advises domestic and international fund managers on the structuring, establishment, and operation of alternative investment schemes across a wide range of asset classes, including private equity and debt, real estate, and venture capital.   He also assists sponsors and institutional investors in connection with their investments in those alternative investment schemes, both in primary and secondary markets.   His experience includes domestic and other European Union funds, corporate
LLamasoft, a specialist in supply chain modelling and design software, has secured an investment from TPG Capital, the global private equity fund of alternative asset firm TPG. With over 700 customers around the world, LLamasoft provides software solutions that help companies think more clearly about their supply chain operations and make better decisions to improve service, reduce cost and mitigate risk.   LLamasoft’s technology includes Supply Chain Guru, the global standard for supply chain design, and this year LLamasoft is rolling out multiple new disruptive applications in the areas of supply chain visibility, planning, and demand modelling. The innovation behind
Kirkland & Ellis International has appointed Volkmar Bruckner as a partner in the firm’s Munich office in the corporate practice group. Bruckner focuses his practice on private equity and M&A.      Bruckner joins Kirkland from the Munich office of Weil Gotshal & Manges where he has been a partner since 2015. Prior to Weil, he was a partner at Latham & Watkins for eight years. He is admitted to practice both in Germany and in New York.    Bruckner advises private equity investors, management teams and corporations on complex domestic and cross-border transactions. His particular focus is on leveraged

Special Reports

Featured

Events

16 May, 2024 – 8:30 am

Directory Listings